Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Yankees Place Giancarlo Stanton On 10-Day Injured List

By | at

3:26PM: Stanton confirmed to Hoch and other reporters that he did get a PRP shot today, and estimated that he’ll spend about four weeks on the IL.

3:10PM: Stanton might receive a PRP injection but the strain is considered “mild,” Boone told MLB.com’s Bryan Hoch and other reporters.  The Yankees don’t yet have a timeline on when Stanton might return to action.

9:42AM: The Yankees announced this morning that they’ve placed slugger Giancarlo Stanton on the 10-day injured list. Infielder Oswald Peraza was recalled to the big league roster in the corresponding move, as first reported by El Extrabase’s Daniel Alvarez-Montes last night.

Stanton, 34, departed yesterday’s game against the Braves in the top of the sixth inning after feeling tightness in his left hamstring while running the bases earlier in the game. Manager Aaron Boone indicated to reporters (including The Athletic’s Brandon Kuty) after the game that Stanton was scheduled to undergo tests today to determine the severity of the issue but noted that Stanton was in “good spirits” and that the club was hopeful the issue wasn’t too serious. The results of Stanton’s testing today are not yet known, although the club evidently believes that he’ll need to miss at least the next ten days before he can return to action. Being cautious with Stanton, who has a long history of lower half injuries throughout his career, is understandable given the risk of aggravating the hamstring further if he were to attempt to play through the injury.

Even so, it’s a frustrating turn of events for both Stanton and the Yankees given the veteran’s resurgence at the plate to this point in the season. Long one of the game’s most feared sluggers, Stanton posted relatively pedestrian numbers over the past two seasons, slashing just .202/.286/.442. That production was only good for a 103 wRC+ that’s essentially league average, and not particularly close to the value the Yankees were surely hoping to get from a full-time DH who they pay an average of $25MM to annually. The veteran’s production in 69 games this season has been far closer to what the Yankees are surely hoping for from him, as he’s impressed with a .246/.302/.492 slash line (126 wRC+) while crushing 18 home runs in just 281 trips to the plate.

New York will have to go without that strong production in the middle of their lineup for at least the foreseeable future, delivering another blow to an offense that has generally struggled to produce outside of star sluggers Juan Soto and Aaron Judge. Stanton shelved, it’s possible the Yankees could look to improve their outfield defense by placing Trent Grisham in center field, kicking Judge back over to his native right field while allowing Soto to move into a DH role. Grisham has struggled to a wRC+ of just 71 at the plate this year, though his quality work with the glove could still make him a more attractive option than more frequently relying on Oswaldo Cabrera (78 wRC+) or DJ LeMahieu (51 wRC+) outside of their current role splitting time at third base.

Taking Stanton’s place on the roster is Peraza, who has been sidelined for almost the entire season to this point due to a shoulder strain. In 28 games at the Triple-A level since returning from injury, Peraza has struggled to a .178/.313/.215 slash line that suggests he’s unlikely to be the solution for replacing Stanton’s production offensively, although the former consensus top-50 prospect would likely be the club’s best defensive option at third base and could free LeMahieu and Cabrera up for more frequent appearances at DH or first base, where youngster Ben Rice has been getting his first taste of big league action while Anthony Rizzo recovers from a fractured forearm.

Blue Jays Claim Jose Cuas Off Waivers From Cubs

By | at

The Cubs announced this afternoon that right-hander Jose Cuas has been claimed off waivers by the Blue Jays. Cuas was designated for assignment earlier this week in order to make room for righty Ethan Roberts on the club’s 40-man roster. The move puts Toronto’s 40-man roster at capacity.

Cuas, who will celebrate his 30th birthday later this week, made his big league debut with the Royals back in 2022 but was traded to the Cubs in exchange for outfielder Nelson Velazquez at the trade deadline last summer. He was a decent middle reliever for the Royals during his time in Kansas City, pitching to a 4.08 ERA (106 ERA+) with a 4.41 FIP in 79 1/3 innings of work for the club between the 2022 and ’23 campaigns. Unfortunately for both Cuas and the Cubs, the wheels began to come off for the sidearming righty upon his arrival in Chicago last year.

While his 3.04 ERA in 27 appearances for the Cubs down the stretch last summer was actually fairly strong, it came with concerning peripherals. His strikeout rate dipped from a strong 27.1% during his time with the Royals last year to a worrisome 19% in Chicago, while his walk rate simultaneously ballooned from a manageable 10% figure in Kansas City all the way up to 14% for the north siders. While a strong 55.6% groundball rate allowed Cuas to keep the damage to a minimum, he was no longer looking the part of a quality middle relief option.

Things took an even worse turn for Cuas in 2024 when his groundball rate plummeted to just 31%. While his walk rate dropped down to a career-best 9.2% figure, that came at least in part as a result of opposing hitters teeing off Cuas pitches with a 14.3% barrel rate and a 45.2% Hard Hit rate. While Cuas’s strikeout rate crept back up to a more acceptable 21.5% this year, that still wasn’t enough to stop the right-hander from surrendering 12 runs (11 earned) in 13 1/3 innings of work for the Cubs this year, leaving him with a 7.43 ERA and a 5.99 FIP.

Despite those deep struggles during his time in Chicago, it’s not hard to see why the Blue Jays would want to take a chance on the righty. After all, when Cuas’s arsenal is working well, his sinker/slider combo allows him to strike out around a quarter of the batters he faces while keeping walks to a clip of around 10% and eliciting grounders on around half of his batted balls. That’s certainly the profile of a valuable pitcher, even though Cuas has not been able to put it all together at the big league level yet during his career.

Even if he isn’t able to reach that potential, the right-hander still provides the Blue Jays with an optionable relief arm on a minimum salary who can be shuttled from Triple-A to the majors as necessary. That’s a valuable commodity for any bullpen, but especially for a Blue Jays bullpen that has posted a league-worst 4.83 FIP to this point in the 2024 campaign. Should the club turn to Cuas at some point, he’d likely factor into the middle relief mix alongside the likes of Zach Pop and Genesis Cabrera.

Rockies Reinstate Kyle Freeland From 60-Day Injured List

By | at

TODAY: The Rockies announced that they’ve activated Freeland from the 60-day IL. To make room for Freeland on the 40-man roster, lefty Austin Kitchen was designated for assignment. Kitchen was selected to the roster just yesterday and did not make an appearance in the majors during his brief stint with the big league club. The Rockies will now have one week to either trade Kitchen or attempt to pass him through waivers.

June 20: The Rockies will welcome Kyle Freeland back to the rotation for Sunday’s game against the Nationals. Colorado’s Opening Day starter has been out since April 19 because of an elbow strain.

Freeland avoided surgery despite that alarming diagnosis. He has made a trio of rehab appearances — one at the complex before a pair of games for Triple-A Albuquerque. Freeland made his most recent outing on Tuesday, tossing four innings while running his pitch count to 67. The veteran southpaw allowed only three runs over eight Triple-A frames.

The Rox will hope that kickstarts a turnaround for Freeland, who was battered over his first four starts of the season. He averaged fewer than four innings per appearance and was tagged for 25 runs across 15 2/3 frames. Freeland issued eight walks with nine strikeouts and allowed a trio of home runs.

Freeland is on the 60-day injured list, so the Rox will need to reinstate him onto the 40-man roster. They opened a 40-man spot earlier in the week by placing reliever Gavin Hollowell on waivers. Unless they make another 40-man transaction in the intervening three days, they’ll only need to option out a pitcher to clear space for Freeland on the active roster.

In other Colorado injury news, manager Bud Black told reporters that rookie infielder Adael Amador suffered a mild oblique strain in today’s loss to the Dodgers (relayed on X by Patrick Saunders of the Denver Post). While it doesn’t seem to be a long-term concern, Amador will probably land on the 10-day injured list. Colorado promoted Amador directly from Double-A Hartford earlier this month when Brendan Rodgers went on the IL.

It was a surprisingly aggressive promotion for one of the organization’s top prospects. The 21-year-old was hitting only .194/.337/.329 in Double-A. That made it quite unlikely that he’d produce in his first look at big league arms. Amador has struggled as expected, hitting .171 with one walk in his first 36 plate appearances.

Black suggested earlier in the week that the Rox planned to option Amador back to Double-A once Rodgers was ready to return (X link via Luke Zahlmann of the Denver Gazette). An injured list stint would delay that, but he’ll probably head back to Hartford once he’s healthy. Rodgers started a rehab assignment in Albuquerque tonight and could be back in the next few days.

Rangers Activate Max Scherzer

By | at

TODAY: The Rangers officially activated Scherzer from the 60-day injured list this morning. Right-hander Yerry Rodriguez was optioned to Triple-A in the corresponding move.

June 22: Max Scherzer’s 2024 debut date has now been set, as the future Hall-of-Famer told reporters (including MLB.com’s Kennedi Landry) that he will be activated from the 60-day injured list tomorrow to start the Rangers’ game against the Royals.  It will mark Scherzer’s first action in a big league contest since he pitched three scoreless innings in Game 3 of last year’s World Series.

Last December, the 39-year-old underwent surgery to fix a herniated disc in his back, and the initial timeline indicated Scherzer would be out of action until June or July.  As it happened, Scherzer looked to be on pace to handily beat that projection and was seemingly close to returning by mid-May before a nerve problem in his thumb extended his time on the IL.  Texas had optimistically put Scherzer on only the 15-day IL to begin the season, but eventually shifted him to the 60-day once it became clear he wouldn’t be back by the end of May.

However, all systems are now go for the veteran righty to make his return.  Scherzer has made two Triple-A starts during his most recent rehab assignment, including a 79-pitch, 4 2/3 inning effort last Saturday.  Texas manager Bruce Bochy told Landry and other reporters that Scherzer wouldn’t be on a specific pitch count in Sunday’s game, though it stands to reason that the club might somewhat try to ease Scherzer back into action.

With Scherzer nearing reinstatement from the 60-day IL, the Rangers are a step closer to finally having their first-choice rotation.  Jacob deGrom and Tyler Mahle could both make their own returns from Tommy John surgery rehab around the start of August, while Cody Bradford continues to recover from a stress fracture in his rib.  On paper the Rangers might have too many rotation options if absolutely everyone is healthy, yet that scenario is probably unlikely given how many health issues Texas has had to navigate over the last year.

Bochy said that Scherzer will take Dane Dunning’s spot in the rotation, moving Dunning back to relief work.  Dunning began 2023 in the bullpen but soon resumed his usual starting role while filling in for various injured starters, primarily deGrom.  Working solely as a starter in 2024, Dunning has a 4.73 ERA over 59 innings.

Marlins Place Braxton Garrett On 15-Day Injured List With Forearm Flexor Strain

By | at

The Marlins announced several roster moves this morning, headlined by the club placing left-hander Braxton Garrett on the 15-Day injured list with a left forearm flexor strain. The club also optioned right-hander Shaun Anderson to Triple-A. Taking Garrett and Anderson’s spots on the club’s active roster will be right-hander Kyle Tyler and left-hander Kent Emanuel, both of whom had their contracts selected. Left-hander Jesus Luzardo and right-hander Edward Cabrera were both transferred to the 60-day injured list to clear space for the duo on the 40-man roster.

Garrett’s placement on the injured list isn’t necessarily a surprise, as the club had already scratched him from today’s start due to elbow soreness yesterday. With that being said, the diagnosis of a forearm flexor strain is a concerning one that suggests Garrett could be in for a lengthy absence, though details about his exact timeline are not yet available. For Marlins fans, it surely brings to mind September of last year, when the Marlins provided the same diagnosis for right-hander Sandy Alcantara before the ace ultimately required Tommy John surgery.

Fortunately, not all forearm strains require such drastic treatment. Nationals right-hander Josiah Gray suffered a similarly-termed strain back in April that ultimately proved to be purely muscular without damage to the UCL. Gray is currently on a rehab assignment and could factor into the Nationals’ pitching plans prior to the All Star break, roughly three months after the initial injury. A similar timeline could see Cabrera return sometime in September, prior to the end of the 2024 campaign.

Regardless of when Cabrera winds up being able to return to the club, however, the Marlins figure to be in a bit of a pickle as they look to piece together their rotation mix. Miami currently has seven starters on the injured list, leaving them with lefty Trevor Rogers, righty Roddery Munoz, and righty Yonny Chirinos as their only three established starting pitchers. That trio will be joined by Tyler, who is slated to start today’s game against the Mariners. A 20th-round pick by the Angels in the 2018 draft, the righty has made eight multi-inning relief appearances in the big leagues since he first made his MLB debut back in 2021, though he’s never started a game at the big league level.

He’s pitched fairly well in his limited opportunities in the majors with a 2.45 ERA and 4.36 FIP in 18 1/3 innings of work. That includes a single appearance with the Marlins earlier this year where he allowed one run in two frames where he allowed one hit and no walks with one strikeout. It’s unclear if Tyler will continue to pitch as part of the club’s rotation after today or if this is a spot start for the 27-year-old. Also joining Tyler on the active roster is the lefty Emanuel, who has been shuttling between the 40-man roster and the minor leagues all throughout the 2024 campaign for the Marlins. In 8 1/3 innings of work for the club this year across four appearances, Emanuel has struggled to a 7.56 ERA with an 8.19 FIP. Nonetheless, the southpaw will provide the club with a multi-inning option out of the bullpen who could piggyback with the right-handed Tyler if necessary this afternoon.

As for Luzardo and Cabrerea, the 60-day IL placements come as a mild surprise for both players. In Luzardo’s case, the lefty was placed on the IL just yesterday with a lumbar stress reaction, and manager Skip Schumaker suggested that injury typically has a 4-6 week timeline. Now that Luzardo is out for at least the next two months, it’s safe to say the Marlins believe he’ll be out for longer than that general timeline. He’ll first be eligible to return from the shelf in late August. Cabrera’s placement also somewhat surprising given the fact that he’s already built up to the 50-pitch range on a rehab assignment, though given the fact that the righty would be eligible to be activated from the shelf in just two weeks it could be a purely procedural transaction.

Orelvis Martinez Receives 80-Game Suspension Following Positive PED Test

By | at

The MLB commissioner’s office announced this morning that Blue Jays infielder Orelvis Martinez has received an 80-game suspension without pay after testing positive for Clomiphene, a banned performance enhancing substance. The suspension is effective immediately. Martinez has since been placed on the restricted list, and the Blue Jays have selected the contract of outfielder Steward Berroa to replace the infielder on the active and 40-man rosters.

“The Blue Jays fully support Major League Baseball’s Joint Drug Prevention and Treatment Program, and strongly believe in keeping the game on a level playing field,” Blue Jays GM Ross Atkins said in a statement this morning. “We were both surprised and disappointed to hear of Orelvis Martinez’s suspension. We will do everything in our power to ensure Orelvis has learned from this mistake. Orelvis has our support, and we know he will get through this.”

Martinez released a statement of his own via the MLB Players Association:

“For the past two years, I have been trying to start a family with my girlfriend. During the offseason, we visited a fertility clinic in the Dominican Republic and after getting lab work done, we were prescribed a treatment, which included a medication called Rejun 50. Unfortunately, Rejun 50 contains a banned substance called Clomiphene.

We wanted to keep this matter private, even within our family, and trusted the doctor who assured us this treatment did not include performance enhancing drugs. Therefore, I made the mistake of not disclosing this to my team or the MLBPA. With that said, I took full responsibility for my actions and accepted my suspension.

I want to apologize to my teammates in both Buffalo and Toronto, the Blue Jays organization, and most importantly, the fans who have supported me during my career. I will learn from this experience and come back to the field in September.”

The news is a major blow to the Blue Jays, who recalled Martinez for his big league debut just this past week to join the club’s infield mix after shortstop Bo Bichette hit the injured list with a calf strain. Martinez has just one game under his belt in the majors so far, having gone 1-for-3 with a strikeout while playing second base in his big league debut on Friday. While Martinez’s big league career had only just begun, he’s long been considered a consensus top-100 prospect in the sport and was in the midst of an excellent showing at Triple-A this year when he received the call to the majors. In 63 games for the club’s Buffalo affiliate this year, Martinez slashed .260/.343/.523 while playing both second and third base.

Now, Martinez’s big league career is on hold just days after it first began. The earliest he’ll be able to return to play in the big leagues is September 23 against the Red Sox, although given the fact that Martinez would be ineligible to participate in the postseason due to his suspension and that date landing just six games before the end of the regular season, it wouldn’t be a surprise if Martinez did not end up returning to the majors until the 2025 campaign.

Fortunately for the Blue Jays, the club has plenty of options at its disposal to fill out the club’s infield mix while Bichette is injured, even without Martinez. Isiah Kiner-Falefa has stepped into the everyday role at shortstop since Bichette hit the shelf last week, and the club figures to mix and match between Davis Schneider, Ernie Clement, Addison Barger, and Spencer Horwitz at second and third base while Bichette is away. The addition of Berroa to the roster mix should allow Schneider to mix into the infield more frequently than he has in recent weeks, as he’s split time between the keystone and left field to this point in the season.

As for Berroa, the 25-year-old made his pro debut with the Jays back in 2017 and has worked his way through the club’s minor league system since then, ultimately reaching Triple-A late last year. He struggled in that initial cup of coffee but has hit fairly well in 62 games at the highest level of the minors this season with a .295/.380/.451 slash line across 222 trips to the plate. Berroa figures to factor into the club’s outfield mix behind regulars Daulton Varsho, Kevin Kiermaier, and George Springer alongside Schneider.

Phillies Place Taijuan Walker On 15-Day Injured List

By | at

The Phillies announced this morning that they’ve placed right-hander Taijuan Walker on the 15-day injured list due to inflammation in his right index finger. Right-hander Michael Mercado was recalled to the majors in a corresponding move. Mercado’s first appearance will be his big league debut.

Walker, 32 in August, has had a difficult 2024 season as he’s dealt with both injuries and ineffectiveness. A shoulder impingement delayed his season debut until the tail end of April, and he’s struggled considerably in ten starts since then. The righty sports a 5.60 ERA and 5.77 FIP overall on the season, figures that are 37% and 40% worse than the league average respectively. Just two of Walker’s ten appearances have been quality starts, and opponents have batted an eye-popping .278/.353/.511 against him in seven starts dating back to May 16. In other words, Walker’s opponents have teed off in recent weeks to achieve results roughly comparable to those Guardians star Jose Ramirez (.271/.330/.528) has posted this season.

Walker’s struggles came to a head Friday night against the Diamondbacks, when the righty allowed four runs on five hits and three walks across just four innings of work while striking out only three batters. Manager Rob Thomson told reporters (as noted by MLB.com’s Injury Tracker) yesterday that Walker was dealing with a “hot spot” on his finger and suggested that the issue has “been probably going on for a while.” Specifically, Thomson suggested that the injury may have impacted the efficacy of Walker’s splitter. The splitter was Walker’s most commonly used pitch last year, when he threw it 33.2% of the time according to Statcast. That usage has dropped to just 17.4% in 2024, and MLB.com notes that he’s thrown the pitch just sixteen times total over his past two starts.

That drop in usage has corresponded with a drop in efficacy. 2023 saw opposing hitters hit just .205 against Walker’s splitter, with a .295 slugging percentage and a .257 wOBA. Those strong results are a far cry for what the right-hander has produced with the pitch this year, as opponents have hit a whopping .426 with a .704 slugging percentage and a wOBA of .477. That .426 figure is the highest average allowed by Walker on any pitch this year, in sharp contrast to last year where his splitter boasted a lower average against than any pitch in his repertoire except for his rarely-used sweeper.

Given the fact that Walker’s finger issue has seemingly impacted his ability to throw his most important pitch, it’s hardly a surprise that the right-hander has suffered such extreme difficulties to this point in the season. Going forward, the Phillies will sit the righty down for at least the next two weeks in order to give the inflammation time to settle down. It’s surely a fairly easy decision for Philadelphia to not have Walker continue to try and play through the issue given the presence of right-hander Spencer Turnbull. Turnbull has been excellent for the club this year while swinging between the rotation and the bullpen, with a 2.63 ERA and 3.57 FIP in 51 1/3 innings across 16 appearances (six starts).

While Turnbull has not started a game since late April, the righty threw 49 pitches in his most recent outing on Friday and figures to be able to step into the rotation and offer the Phillies solid production in Walker’s stead. That leaves the long relief role out of the bullpen to Mercado, who is set to replace Walker on the club’s roster. Mercado was the Rays’ second-round pick in the 2017 draft but did not make an appearance at the big league level with the club before being traded to the Phillies back in November. Philadelphia swiftly placed Mercado on their 40-man roster and sent him to Triple-A to open the season, where he’s excelled with a 1.71 ERA and a 22.8% strikeout rate in 47 1/3 innings of work split between the rotation and bullpen at the level.

Dave Dombrowski Discusses Cristopher Sanchez Extension, Ranger Suarez’s Future

By | at

When the Phillies announced a four-year extension with young left-hander Cristopher Sanchez yesterday, president of baseball operations Dave Dombrowski revealed to reporters (including Matt Gelb of The Athletic) that the deal isn’t one they would have considered making if Sanchez and his agent, Gene Mato, hadn’t approached him about the possibility of a long-term deal. Even at that point, Dombrowski noted that he had some reservations about negotiating in-season.

“As much as we’d love to have him, during the middle of the season, it’s not normally something that I would like to get into,” Dombrowski said, as relayed by Gelb. “Because it can be a distraction for the player.”

Fortunately, the extension talks didn’t take very long as Gelb notes that it took just one week of negotiations before the sides settled on the four-year, $22.5MM guarantee with two club options that could extend the club’s window of control over Sanchez through the end of the 2030 campaign. The smooth negotiations between Dombrowski and Sanchez’s camp appear to have been crucial in pushing the deal across the finish line given the Phillies’ stated concerns that a protracted negotiation process could become a distraction from the season at hand.

That apparent trepidation with regards to in-season extensions could serve as a clue for how the Phillies will approach left-hander Ranger Suarez, who Gelb notes the Phillies have interest in extending. Suarez is currently slated to hit free agency following the 2025 season, but Gelb notes that talks have yet to progress between the sides and appear likely to wait until after the 2024 campaign has concluded. For his part, Dombrowski noted that the club “love[s]” Suarez and that they “hope that he’s part of the organization for a long time,” but also declined to discuss the state of negotiations with the lefty.

If the Phillies want to extend Suarez, it’s sure to come with a much heftier price tag than the Sanchez extension. Sanchez’s deal is more or less in line with the low end of what pitchers in his service time bracket have received in extensions, just ahead of the $18.8MM guarantee the Red Sox gave to right-hander Garrett Whitlock but a far cry from the $50M+ guarantees afforded to Boston’s Brayan Bello and Cincinnati’s Hunter Greene. Suarez, who will be just one year from free agency this offseason, is in a completely different realm of contract expectations.

The two hurlers to sign extensions with just one year to go before free agency in recent memory are Mariners right-hander Luis Castillo and Blue Jays right-hander Jose Berrios, both of whom did so shortly after being dealt to new teams the previous summer. Castillo signed a $108MM guarantee over five years with Seattle, while Berrios signed in Toronto on a seven-year deal that guaranteed him $131MM. Both hurlers had a much longer track record of success in the starting rotation at the time of their extensions than Suarez, who didn’t become a full-time starting pitcher until the 2022 season.

On the other hand, however, Suarez has undeniably been more dominant than either hurler in the years leading up to the start of extension negotiations. The lefty has pitched to a 2.91 ERA (142 ERA+) with a 3.39 FIP in 478 2/3 innings of work since the start of the 2021 season. That eclipses the work of both Berrios (118 ERA+, 3.78 FIP) and Castillo (132 ERA+, 3.43 FIP) on a rate basis in their final four years before signing, though both Castillo and Berrios had 120+ additional innings of work over that same timeframe. Much of Suarez’s ultimate price tag will surely depend on how he finishes the 2024 campaign; the lefty currently leads all of MLB with an incredible 1.75 ERA through 15 starts this year and figures to find himself in the thick of the Cy Young conversation at year’s end if he can keep anything close to this production up over a full year.

Phillies Extend Cristopher Sanchez

By | at

3:25PM: According to The Athletic’s Matt Gelb, the extension will guarantee Sanchez $22.5MM in total. The club option year for 2029 is valued at $14MM, while the 2030 club option is worth $15MM. Gelb adds that the price of both options will rise if Sanchez manages to finish in the top 10 of NL Cy Young award voting.

10:33AM: The Phillies have officially announced the extension, with no financial terms released.  Sanchez’s deal covers the 2025-28 seasons, and Philadelphia has club options on his services for both 2029 and 2030.

9:10AM: The Phillies and left-hander Cristopher Sanchez are in the final stages of completing a four-year contract extension, the New York Post’s Jon Heyman reports (X link).  Sanchez is already under team control through the 2028 season, so the deal will give the Phils some cost certainty over those upcoming four years and beyond.  Heyman indicates there are multiple club option years, so the Phillies can now control at least two of Sanchez’s free agent seasons.  The 27-year-old Sanchez is represented by agent Gene Mato.

The signing continues Philadelphia’s penchant for locking up arms, as all of the extensions signed during Dave Dombrowski’s tenure as president of baseball operations have come on the pitching end.  These deals range from shorter-term deals to avoid arbitration to the much pricier three-year, $126MM extension Zack Wheeler signed last March, and Sanchez’s deal should fall somewhere in between.

Considering Sanchez’s relatively advanced age (he turns 28 in December) and the fact that he isn’t even eligible for arbitration until the 2025-26 offseason, an extension is an aggressive move on the part of Dombrowski’s front office.  While the southpaw was lining himself up well for some nice salaries in his arb years, having a relatively inexpensive arm in the rotation could have helped balance out the much larger luxury tax hits of pricier players like Wheeler, Bryce Harper, Trea Turner, and Aaron Nola, all of whom are signed through at least the 2027 season.  Nick Castellanos and Taijuan Walker also on the books through 2026, J.T. Realmuto and Kyle Schwarber through 2025, and the likes of Ranger Suarez, Alec Bohm, and Bryson Stott have also played well enough to merit consideration for long-term commitments.

The Phillies surpassed the luxury tax threshold in each of the last two seasons and are set to do again in 2024, as the team has shown it is more than willing to spend big in pursuit of a championship.  Against this backdrop, it isn’t surprising that the Phils are again opening the checkbook to retain a player they like, and who they feel might end up being something of a bargain over the course of the extension, considering how Sanchez has emerged as a starter in 2023-24.

An international signing for the Rays out of the Dominican Republic in 2013, Sanchez was dealt to Philadelphia in November 2019 in a one-for-one trade for Curtis Mead.  An under-the-radar move at the time, it has become a pretty intriguing deal in hindsight given how Sanchez has developed as a capable MLB starter, and how Mead went on to become a top-100 prospect in Tampa’s farm system (and a big leaguer himself, albeit in only 50 games to date).

Sanchez showed some flashes of his future ability as a starter and a reliever during his time in the Rays’ farm system, and the Phillies used him mostly as a starter during his time in the minors.  He made his MLB debut in 2021 and still worked as a reliever in all but four of his big league outings (52 2/3 innings over 23 appearances) in 2021-22, but some injuries opened the door for Sanchez to eventually step into the Philadelphia rotation himself last season.  The result was a 3.44 ERA over 99 1/3 innings, supported by a 24.2% strikeout rate, a four percent walk rate, and a 57% grounder rate.

That success has largely carried over to this season, as Sanchez has a 2.91 ERA, 20.3% strikeout rate, 7.4% walk rate, and a 59.4% grounder rate.  While the walk rate is no longer elite and Sanchez’s K% is now below average, he is still generating tons of grounders, and could even be considered somewhat unlucky since he has a .342 BABIP.  Sanchez is doing a solid job of limiting hard contract and in particular of keeping the ball in the park — after allowing 16 homers in his 99 1/3 innings in 2023, Sanchez has given up just one home run in 77 1/3 frames this year.  While not a particularly hard thrower in relation to the rest of the league, Sanchez has added quite a bit of velocity, now averaging 94.3mph on his fastball after averaging 92.1mph last year.

This grounder-heavy and relatively low-strikeout skillset could lend itself to some variance if the ground balls start finding holes in the infield, or if Sanchez’s newfound success at limiting homers doesn’t continue.  That said, the Phillies are obviously confident enough in Sanchez as a viable rotation member that they have now firmed up their commitment to him for much of the decade.

From Sanchez’s perspective, he’ll now land the first big payday of his professional career.  Since he wouldn’t have entered free agency until after his age-31 season, Sanchez will gain some life-changing financial ability now, rather than run the risk that an injury or a dip in form might’ve scuttled his future chances at a big multi-year contract.

Looking at the bigger picture of the Phillies’ pitching situation, extending Sanchez creates some new questions about whether or not retaining Suarez is also in the team’s plans.  Suarez is eligible for arbitration one more time before hitting the open market after the 2025 campaign, and the left-hander’s breakout as a Cy Young Award candidate this season will surely elevate his asking price.  With so much money already committed to the rotation in particular, retaining Sanchez could be the Phillies’ way of creating a hedge if Suarez does depart in free agency, though it wouldn’t be surprising if the Phils again break the bank to keep Suarez on yet another noteworthy extension.

With so much of their rotation now locked up, the Phillies have limited room on paper for top pitching prospects Andrew Painter and Mick Abel.  This could make Philadelphia more open to moving young pitching for more immediate help at this year’s trade deadline, though it should be noted that Abel hasn’t performed well at Triple-A this season and Painter won’t pitch until 2025 due to Tommy John surgery.  Until the Phils have more clarity on their top young arms in particular, Dombrowski would certainly be wary of dealing from the starting ranks.  Spencer Turnbull has excelled when used as a starter this season as well, though he is only signed through this season.

Photo courtesy of USA Today Sports Images

Dodgers Notes: Kershaw, May, Graterol

By | at

Longtime Dodgers ace Clayton Kershaw has been sidelined for the entirety of the 2024 season to this point after undergoing shoulder surgery over the offseason, but recently began a rehab assignment as he eyes a potential return sometime next month. That rehab assignment has already hit a snag, however, as manager Dave Roberts told reporters (including Bill Plunkett of the Orange County Register) today that the veteran southpaw has felt “a little bit of soreness” in the aftermath of his rehab start for the club’s High-A affiliate in Rancho Cucamonga earlier this week.

That soreness continued today for the veteran lefty when he threw a light bullpen session, and Roberts indicated that the club is considering pushing back his next rehab start- which is currently scheduled for Tuesday- depending on how he feels in the coming days. Kershaw is expected to play catch tomorrow, and how he feels after that session could determine whether or not the Dodgers go ahead with the planned outing. The potential setback is a frustrating one, as a relatively speedy return by Kershaw would be hugely impactful for a rotation that recently lost both Yoshinobu Yamamoto and Walker Buehler to the injured list.

Those injuries left the Dodgers to turn to rookie right-hander Landon Knack in the fifth starter role behind Tyler Glasnow, Bobby Miller, Gavin Stone, and James Paxton. Outside of that group of five, however, the club is lacking in starting depth meaning further injuries could prove problematic for the club. Even setting aside L.A.’s quickly evaporating rotation depth, it’s worth noting that the 36-year-old lefty is almost assuredly one of the club’s five best starters to begin with; after all, the future Hall of Famer hasn’t posted an ERA north of 3.55 since his rookie campaign back in 2008 and managed to put together a 2.46 ERA across 24 starts last year despite playing through shoulder issues.

Roberts also provided more positive injury updates to reporters (including Jack Harris of the Los Angeles Times) this evening regarding right-handers Dustin May and Brusdar Graterol. The manager indicated that both pitchers have begun to throw bullpen sessions and called the sessions “promising.” While the timelines for each player’s return are still unclear, Roberts expressed confidence that both would return to action before the 2024 season comes to a close.

May, 26, has had a frustrating MLB career to this point. The righty debuted late in his age-21 season back in 2019 and enjoyed some success over his first two big league campaigns, with a 2.98 ERA and 3.96 FIP in 90 2/3 innings of work, first out of the bullpen in 2019 and then as a member of the rotation during the shortened 2020 campaign. May went on to win the World Series with L.A. during the pandemic-shortened campaign while pitching out of the bullpen during the postseason but returned to the rotation in 2021.

Unfortunately, he made it just five starts into the 2021 campaign before undergoing Tommy John surgery and has not put together a wire-to-wire big league season since. While the right-hander has pitched to an impressive 3.21 ERA and 3.59 FIP since the start of the 2021 campaign, he’s also been limited to just 101 innings across 20 starts during that time by the aforementioned Tommy John and a flexor tendon procedure he underwent in last July. It’s not clear whether the Dodgers hope to return May to the rotation upon his return to action or if he’ll be ticketed for the bullpen, but if healthy he figures to be an impactful arm for the club in whatever role he takes on.

As for Graterol, the 25-year-old hurler has been one of the club’s most reliable relievers since he was acquired from the Twins prior to the 2020 season. In 173 2/3 innings of work for the club since then, Graterol has pitched to an exceptional 2.69 ERA with a 3.24 FIP. He’s struck out just 18.9% of batters faced during that time but has generated an extraordinary 62.5% groundball rate as a Dodger while limiting free passes to just a 5.5% rate. Graterol figured to once again factor into the club’s high-leverage plans at the back of the bullpen this year until those plans were scuttled by a shoulder injury during Spring Training that eventually led the club to shut the righty down in late April. Should he return before the end of the season, he’d likely return to the back of the club’s bullpen alongside closer Evan Phillips.

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top